LENSAR, Inc. (LNSR) 8-K Current Report: March 13, 2026
Filed: March 13, 2026
Health Care
Surgical & Medical Instruments & ApparatusLENSAR, Inc. (LNSR) 8-K current report filed with SEC EDGAR on March 13, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 8.01: Other Events
LENSAR, Inc. 8-K Mar 13, 2026 Event Analysis
Item 8.01 · Other Events
- • Revolving margin credit facility with Wells Fargo secured by brokerage account collateral, not operating assets
- • Borrowing capacity up to $9.2M based on current collateral value in designated Wells Fargo account
- • Interest at borrower's election: fixed (Treasury Yield + margin) or variable (SOFR + margin)
- • Collateral-backed structure limits dilution risk vs. equity raise, but collateral shortfall triggers immediate default
Other LENSAR, Inc. 8-K Filings
Get deeper insights on LENSAR, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.